2m 2m 2m 2m 2m 2m 2m
Johnson&Johnson (JNJ)
NYSE
$235.45+$4.16 (+1.80%)
Price as of Jun 23, 2026 11:43 AM EDT- $556.8BMarket Cap
- 56.67%1-Year Change
- Drug Manufacturers - GeneralIndustry
Johnson&Johnson (JNJ)
$235.45+$4.16 (+1.80%)
Annual
Quarterly
12/28/2025 | 12/29/2024 | 12/31/2023 | 01/02/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 94.2B +6.05% | 88.8B +4.30% | 85.2B -9.19% | 93.8B +13.55% | |
Cost of Revenue | 30.3B +10.14% | 27.5B +3.46% | 26.6B -11.06% | 29.9B +5.02% | |
Gross Profit | 63.9B +4.22% | 61.4B +4.68% | 58.6B -8.31% | 63.9B +18.03% | |
Sales and Marketing Expense | 23.7B +3.53% | 22.9B +6.31% | 21.5B -12.76% | 24.7B +11.66% | |
Research and Development Expense | -14.7B -14.90% | -17.2B +14.23% | -15.1B -3.39% | -15.6B +26.53% | |
Depreciation and Amortization Expense | 7.5B +2.23% | 7.3B -1.96% | 7.5B +1.30% | 7.4B +2.20% | |
Total Operating Expenses | 30.3B +10.14% | 27.5B +3.46% | 26.6B -11.06% | 29.9B +5.02% | |
Operating Profit | 32.6B +95.25% | 16.7B +10.79% | 15.1B -33.87% | 22.8B +38.06% | |
Interest Income | 1.1B -20.72% | 1.3B +5.63% | 1.3B +2,279.25% | 53.0M -52.25% | |
Interest Expense | N/A N/A | N/A N/A | -772.0M +321.86% | -183.0M -8.96% | |
Interest Income and Expense and Net | 1.1B -20.72% | 1.3B +172.39% | 489.0M +476.15% | -130.0M +44.44% | |
Total Nonoperating Income and Expense | 7.2B +253.58% | -4.7B -29.24% | -6.6B +1,256.65% | -489.0M -83.13% | |
Income before Taxes | 32.6B +95.25% | 16.7B +10.79% | 15.1B -33.87% | 22.8B +38.06% | |
Income Taxes | 5.8B +120.41% | 2.6B +50.98% | 1.7B -8.54% | 1.9B +6.45% | |
Extraordinary Items | 204.0M -49.63% | 405.0M -68.73% | 1.3B +30.94% | 989.0M +324.46% | |
Net Income | 26.8B +90.56% | 14.1B -59.99% | 35.2B +68.37% | 20.9B +41.89% | |
Net Income from Continuing Operations Applicable to Common | 26.8B +90.56% | 14.1B +5.55% | 13.3B -41.49% | 22.8B +54.79% | |
Basic EPS and Net Income | 11.13 +90.58% | 5.84 -57.93% | 13.88 +75.03% | 7.93 +41.86% | |
Diluted EPS and Net Income | 11.03 +90.50% | 5.79 -57.80% | 13.72 +75.67% | 7.81 +41.74% | |
Basic Weighted Average Shares | 2.4B +0.004% | 2.4B -4.98% | 2.5B -3.75% | 2.6B -0.03% | |
Diluted Weighted Average Shares | 2.4B 0.00% | 2.4B -5.12% | 2.6B -4.25% | 2.7B +0.12% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 19.7B -18.24% | 24.1B +10.27% | 21.9B +50.89% | 14.5B +3.59% | |
Short-Term Investments | 393.0M -5.76% | 417.0M -60.96% | 1.1B -93.76% | 17.1B +52.87% | |
Cash and Cash Equivalents and Short-Term Investments | 20.1B -18.02% | 24.5B +6.96% | 22.9B -27.46% | 31.6B +25.50% | |
Total Current Assets | 55.6B -0.48% | 55.9B +4.48% | 53.5B -12.27% | 61.0B +19.01% | |
Accumulated Depreciation | 31.2B +10.42% | 28.3B +1.33% | 27.9B -2.92% | 28.7B +2.42% | |
Property and Plant and Equipment and Net | 23.2B +12.92% | 20.5B +3.12% | 19.9B +4.94% | 19.0B +1.04% | |
Total Long-Term Assets | 14.4B +25.88% | 11.4B -19.35% | 14.2B +38.54% | 10.2B +55.68% | |
Total Assets | 199.2B +10.61% | 180.1B +7.49% | 167.6B -7.94% | 182.0B +4.07% | |
Income Taxes Payable | 8.7B +31.09% | 6.6B -27.10% | 9.1B -36.65% | 14.3B -5.62% | |
Total Short-Term Debt | 8.5B +41.99% | 6.0B +73.37% | 3.5B -8.36% | 3.8B +43.14% | |
Total Current Liabilities | 54.1B +7.56% | 50.3B +8.73% | 46.3B +2.33% | 45.2B +6.43% | |
Total Long-Term Debt | 39.4B +28.67% | 30.7B +18.43% | 25.9B -13.69% | 30.0B -8.12% | |
Total Long-Term Liabilities | 9.9B -43.77% | 17.5B +30.98% | 13.4B +25.38% | 10.7B -10.53% | |
Total Liabilities | 117.7B +8.33% | 108.6B +9.95% | 98.8B -8.53% | 108.0B -3.24% | |
Retained Earnings | 169.0B +8.46% | 155.8B +1.27% | 153.8B +25.01% | 123.1B +8.05% | |
Total Stockholders Equity | 81.5B +14.06% | 71.5B +3.95% | 68.8B -39.20% | 113.1B +11.16% | |
Total Shares Outstanding | 3.1B 0.00% | 3.1B 0.00% | 3.1B 0.00% | 3.1B 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 24.5B +1.09% | 24.3B +6.47% | 22.8B -2.64% | 23.4B -0.54% | |
Capital Expenditures | 4.8B +9.22% | 4.4B -2.62% | 4.5B +24.40% | 3.7B +9.11% | |
Cash from Investing Activities | -23.6B +26.82% | -18.6B -2,218.34% | 878.0M +110.11% | -8.7B -58.30% | |
Dividends Paid | 12.4B +4.72% | 11.8B +0.45% | 11.8B +6.69% | 11.0B +5.26% | |
Cash from Financing Activities | -5.5B +76.85% | -3.1B -80.21% | -15.8B +12.66% | -14.0B +129.53% | |
Financials Ratio | |||||
Gross Margin | 67.88% -1.73% | 69.07% +0.37% | 68.82% +0.96% | 68.16% +3.94% | |
Operating Margin | 34.59% +84.11% | 18.79% +6.22% | 17.69% -27.18% | 24.29% +21.59% | |
Return on Assets | 14.13% +74.66% | 8.09% -59.77% | 20.11% +71.91% | 11.70% +32.23% | |
Return on Equity | 35.03% +74.66% | 20.06% -48.11% | 38.65% +98.92% | 19.43% +31.83% | |
Revenue Growth | 6.05% +40.65% | 4.30% +146.80% | -9.19% -167.80% | 13.55% +2,018.02% | |
Current Ratio | 1.03 -7.47% | 1.11 -3.90% | 1.16 -14.28% | 1.35 +11.82% | |
Cash Ratio | 0.36 -23.99% | 0.48 +1.42% | 0.47 +47.46% | 0.32 -2.67% | |
Debt-to-Equity Ratio | 0.59 +14.72% | 0.51 +20.14% | 0.43 +42.93% | 0.30 -13.88% | |
Debt-to-Assets Ratio | 0.24 +18.29% | 0.20 +16.16% | 0.18 -5.56% | 0.19 -8.04% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow